General anaesthetic actions on ligand-gated ion channels

Cellular and Molecular Life Sciences

Volumn 55, Issue 10, 1999, Pages 1278-1303

  Krasowski, M D ^a   Harrison, N L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acetylcholine; Electrophysiology; GABA; General anaesthesia; Glutamate; Glycine; Ligand gated ion channels; Serotonin

Indexed keywords

ALFAXALONE; ANALGESIC AGENT; ANESTHETIC AGENT; CHLORAL HYDRATE; CHLOROFORM; ETHER; ETOMIDATE; HALOTHANE; ION CHANNEL; ISOFLURANE; KETAMINE; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PENTOBARBITAL; PROPOFOL; RECOMBINANT PROTEIN; XENON;

CENTRAL NERVOUS SYSTEM; CHANNEL GATING; CLINICAL PRACTICE; DRUG EFFECT; DRUG MECHANISM; GENE TARGETING; HUMAN; NONHUMAN; REVIEW;

ANESTHETICS, GENERAL; ANIMALS; CELL MEMBRANE; HUMANS; ION CHANNEL GATING; ION CHANNELS; LIGANDS; MAMMALS; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE;

MAMMALIA;

EID: 0033567181     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050371     Document Type: Review

References (376)

1. 1 Harrison N. L. and Flood P. (1998) Molecular mechanisms of general anesthetic action. Sci. Mod. 5: 18-27
2. 2 Marshall B. E. and Longnecker D. E. (1996) General anesthetics. In: The Pharmacological Basis of Therapeutics, pp. 307-330, Hardman J. G., Limbird L. E., Molinoff P. B., Ruddon R. W. and Gilman A. G. (eds), McGraw-Hill, New York
3. 3 Meyer H. (1901) Zur Theorie der Alkolnarkose: der Einfuss wechseinder Temperatur auf Wirkungsstarke und Theilungscoefficient der Narcotica. Naunyn-Schmiedebergs Arch. Exp. Path. Pharmakol. 46: 338-346
4. 4 Meyer H. (1899) Welche eigenschaft der Anasthetica bedingt ihre Narkotische wirkung? Naunyn-Schmiedebergs Arch. Exp. Path. Pharmakol. 42: 109-118
5. 5 Overton E., Studien uber die Narkose, zugleich ein Beitrag zur allgemeiner Pharmakologie, Gustav Fischer, Jena, Switzerland, 1901
6. 6 Meyer K. H. (1937) Contribution to the theory of narcosis. Trans. Faraday Soc. 33: 1062-1068
7. 7 Mullins L. J. (1954) Some physical mechanisms in narcosis. Chem. Rev. 54: 289-322
8. 8 Seeman P. (1972) The membrane actions or anesthetics and tranquilizers. Pharmacol. Rev. 24: 583-655
9. 9 Franks N. P. and Lieb W. R. (1984) Do general anaesthetics act by competitive binding to specific receptors? Nature 310: 599-601
10. 10 Franks N. P. and Lieb W. R. (1986) The pharmacology of simple molecules. Archiv. Toxicol. Suppl. 9: 27-37
11. 11 Franks N. P. and Lieb W. R. (1981) Is membrane expansion relevant to anaesthesia? Nature 292: 248-251
12. 12 Franks N. P. and Lieb W. R. (1982) Molecular mechanisms of general anaesthesia. Nature 300: 487-493
13. 13 Franks N. P. and Lieb W. R. (1994) Molecular and cellular mechanisms of general anaesthesia. Nature 367: 607-614
14. 14 Franks N. P. and Lieb W. K. (1986) Partitioning of long-chain alcohols into lipid bilayers: implications for mechanisms of general anesthesia. Proc. Natl. Acad. Sci. USA 83: 5116-5120
15. 15 Tomlin S. L., Jenkins A., Lieb W. R. and Franks N. P. (1998) Stereoselective effects of etomidate optical isomers on gamma-aminobutyric acid type A receptors and animals. Anesthesiol. 88: 708-717
16. 16 Elliott J. R. and Urban B. W. (1995) Integrative effects of general anaesthetics: why nerve axons should not be ignored. Eur. J. Anaesth. 12: 41-50
17. 17 Rehberg B., Urban B. W. and Duch D. S. (1995) The membrane lipid cholesterol modulates anesthetic actions on a human brain ion channel. Anesthesiol. 82: 749-758
18. 18 Cantor R. S. (1997) The lateral pressure profile in membranes: a physical mechanism of general anesthetics. Biochemistry 36: 2339-2344
19. 19 Halsey M. J. (1992) Molecular interactions of anaesthetics with biological membranes. Gen. Pharmacol. 23: 1013-1016
20. 20 Eckenhoff R. G. and Johansson J. S. (1997) Molecular interactions between inhaled anesthetics and proteins. Pharmacol. Rev. 49: 343-367
21. 21 Eckenhoff R. G. (1998) Do specific or nonspecific interactions with proteins underlie inhalational anesthetic action? Mol. Pharmacol. 54: 610-615
22. 22 Eccles J. C. and Malcolm J. L. (1946) Dorsal root potentials of the spinal cord. J. Neurophysiol. 9: 139-160
23. 23 Eccles J. C., Schmidt R. and Willis W. D. (1963) Pharmacological studies on presynaptic inhibition. J. Physiol. 168: 500-530
24. A receptor/chloride channel complex in anesthesia. Anesthesiol. 78: 757-776
25. A receptors: electrophysiological studies. In: Molecular Bases of Anesthesia, Moody E. J. and Skolnick P. (eds), CRC Press, Boca Raton, FL, in press
26. 26 Franks N. P. and Lieb W. R. (1996) An anesthetic-sensitive superfamily of neurotransmitter-gated ion channels. J. Clin. Anesth. 8: 3S-7S
27. 27 Harris R. A., Mihic S. J., Dildy-Mayfield J. E. and Machu T. K. (1995) Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition. FASEB J. 9: 1454-1462
28. 28 Franks N. P. and Lieb W. R. (1993) Selective actions of volatile general anaesthetics at molecular and cellular levels. Br. J. Anaesth. 71: 65-76
29. 29 Weight F. F., Lovinger D. M., White G. and Peoples R. W. (1991) Alcohol and anesthetic actions on excitatory amino acid-activated ion channels. Ann. N. Y. Acad. Sci. 625: 97-107
30. 30 Weight F. F., Aguayo L. G., White G., Lovinger D. M. and Peoples R. W. (1992) GABA-and glutamate-gated ion channels as molecular sites of alcohol and anesthetic action. Adv. Biochem. Psychopharmacol. 47: 335-347
31. 31 Peoples R. W. and Weight F. F. (1997) Anesthetic actions on excitatory amino acid receptors. In: Anesthesia: Biologic Foundations, pp. 239-258, Yaksh T. L. (ed.), Lippincott-Raven, Philadelphia
32. A receptor function. Trends Pharmacol. Sci. 16: 295-303
33. A receptors. Cell. Mol. Neurobiol. 16: 155-174
34. 34 Lovinger D. M. (1997) Alcohols and neurotransmitter gated ion channels: past, present and future. Naunyn-Schmiedebergs Arch. Pharmacol. 356: 267-282
35. A receptors. Adv. Biochem, Psychopharmacol. 48: 17-40
36. A receptors. Trends Pharmacol. Sci. 16: 162-168
37. A receptor subtypes. Intl. Rev. Neurobio. 38: 95-138
38. 38 Ortells M. O. and Lunt G. G. (1995) Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 18: 121-127
39. A receptor pharmacology. Pharmacol. Ther. 69: 173-198
40. 40 Kuhse J., Betz H. and Kirsch J. (1995) The inhibitory glycine receptor: architecture, synaptic localization and molecular pathology of a postsynaptic ion-channel complex. Curr. Opin. Neurobiol. 5: 318-323
41. 41 Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F. and Wells G. (1996) Structure and function of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 109: 125-137
42. 42 Xu M. and Akabas M. H. (1993) Amino acids lining the channel of the γ-aminobutyric acid type A receptor identified by cysteine substitution. J. Biol. Chem. 268: 21505-21508
43. 43 Akabas M. H., Kaufmann C., Archdeacon P. and Karlin A. (1994) Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit. Neuron 13: 919-927
44. 44 Langosch D., Thomas L. and Betz H. (1988) Conserved quaternary structure of ligand-gated ion channels: the postsynaptic glycine receptor is a pentamer. Proc. Natl. Acad. Sci. USA 85: 7394-7398
45. 45 Cooper E., Couturier S. and Ballivet M. (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350: 235-238
46. 46 McCormick D. A. (1989) GABA as an inhibitory neurotransmitter in human cerebral cortex. J. Neurophysiol. 62: 1018-1027
47. 47 Zafra F., Aragon C. and Gimenez C. (1997) Molecular biology of glycinergic neurotransmission. Mol. Neurobiol. 14: 117-142
48. 3H]GABA in nerve terminals of cerebral cortex by electron microscopic autoradiography. Nature 229: 628-630
49. A receptor subunit. Nature 385: 820-823
50. A receptor subunit conferring atypical functional properties. J. Neurosci. 17: 5027-5037
51. A receptor subunit in tissues of the reproductive system. J. Biol. Chem. 272: 15346-15350
52. A-receptor subtypes really occur in the brain? Trends Neurosci. 19: 139-143
53. A receptor research. Synapse 21: 189-274
54. A receptors. Biochem. J. 310: 1-9
55. A receptor channels. Annu. Rev. Neurosci. 17: 569-602
56. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50: 291-313
57. 57 Betz H. (1991) Glycine receptors: heterogeneous and widespread in the mammalian brain. Trends Neurosci. 14: 458-461
58. 58 Betz H. (1992) Structure and function of inhibitory glycine receptors. Q. Rev. Biophys. 25: 381-394
59. A receptor subtype. J. Neurosci. 17: 2728-2737
60. A receptor. J. Neurosci. 16: 5415-5424
61. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359: 154-194
62. 62 Nusser Z., Sieghart W., Benke D., Fritschy J. M. and Somogyi P. (1996) Differential synaptic localization of two major γ-aminobutyric acid type A receptor α subunits on hippocampal pyramidal cells. Proc. Natl. Acad. Sci. USA 93: 11939-11944
63. A receptor subtypes. Pharmacol. Rev. 47: 181-234
64. A receptor subunits expressed in Xenopus oocytes. Neuron 1: 773-781
65. A receptors on channel function. Neuron 5: 703-711
66. 66 Ebert B., Wafford K. A., Whiting P. J., Krogsgaard-Larsen P. and Kemp J. A. (1994) Molecular pharmacology of α-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different α, β and γ receptor subunit combinations. Mol. Pharmacol. 46: 957-963
67. A receptor subtypes. Mol. Pharmacol. 43: 240-244
68. A receptor α6 subunit. J. Neurosci. 16: 3630-3640
69. A receptor channels are dependent on α-subunit isoform. Biophys. J. 73: 2518-2526
70. 70 Cutting G. R., Lu L., O'Hara B. F., Kasch L. M., Montrose-Rafizadeh C., Donovan D. M. et al. (1991) Cloning of the γ-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc. Natl. Acad. Sci. USA 88: 2673-2677
71. 1 (GABRR1) to human chromosome 6q14-q21 and mouse chromosome 4. Genomics 12: 801-806
72. C receptors: relatively simple transmitter-gated ion channels? Trends Pharmacol. Sci. 17: 319-323
73. 73 Wegelius K., Pasternack M., Hitunen J. O., Rivera C., Kaila K., Saarma M. et al. (1998) Distribution of GABA receptor ρ subunit transcripts in the rat brain. Eur. J. Neurosci. 10: 350-357
74. 74 Caratsch C. G., Grassi F. and Eusebi F. (1992) Functional regulation of nicotinic acetylcholine receptor channels in muscle. Ion Channels 3: 177-206
75. 75 Conti-Tronconi B. M., McLane K. E., Raftery M. A., Grando S. A. and Protti M. P. (1994) The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit. Rev. Biochem. Mol. Biol. 29: 69-123
76. 76 Galzi J. L., Revah F., Bessis A. and Changeux J. P. (1991) Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu. Rev. Pharmacol. Toxicol. 31: 37-72
77. 77 Gotti C., Fornasari D. and Clementi F. (1997) Human neuronal nicotinic receptors. Prog. Neurobiol. 53: 199-237
78. 78 Lindstrom J. (1996) Neuronal nicotinic acetylcholine receptors. Ion Channels 4: 377-450
79. 79 McGehee D. S. and Role L. W. (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57: 521-546
80. 80 Boyd R. T. (1997) The molecular biology of neuronal nicotinic acetylcholine receptors. Crit. Rev. Toxicol. 27: 299-318
81. 81 McGehee D. S. and Role L. W. (1996) Presynaptic ionotropic receptors. Curr. Opin. Neurobiol. 6: 342-349
82. 82 Frazier C. J., Buhler A. V., Weiner J. L. and Dunwiddie T. V. (1998) Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci. 18: 8228-8235
83. 3 receptor mRNA. Proc. Natl. Acad. Sci. USA 90: 1430-1434
84. 84 Fletcher S. and Barnes N. M. (1998) Desperately seeking subunits: are native 5-HT, receptors really homomeric complexes? Trends Pharmacol. Sci. 19: 212-215
85. 3 receptor channel. Annu. Rev. Physiol. 57: 447-468
86. 3 receptors: pharmacologic and therapeutic aspects. J. Clin. Pharmacol. 35: 845-855
87. 3 receptors in drug dependence. Drug Alcohol Depend. 38: 155-171
88. 3 receptors in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci. Lett. 208: 203-207
89. 89 Bennet J. A. and Dingledine R. (1995) Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop. Neuron 14: 373-384
90. 90 Hollmann M., Maron C. and Heinemann S. (1994) N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron 13: 1331-1343
91. 91 Sutcliffe M. J., Wo Z. G. and Oswald R. E. (1996) Three-dimensional models of non-NMDA glutamate receptors. Biophys. J. 70: 1575-1589
92. 92 Wo Z. G. and Oswald R. E. (1994) Transmembrane topology of two kainate receptor subunits revealed by N-glycosylation. Proc. Natl. Acad. Sci. USA 91: 7154-7158
93. + channel signature sequence. Biophys. J. 66: 1061-1067
94. 94 Rosenmund C., Stern-Bach Y. and Stevens C. F. (1998) The tetrameric structure of a glutamate receptor channel. Science 280: 1596-1599
95. 95 Laube B., Kuhse J. and Betz H. (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18: 2954-2961
96. 96 MacKinnon R. (1991) Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 350: 232-235
97. 97 Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D. et al. (1998) Glutamate receptors: brain function and spinal transduction. Brain Res. Brain Res. Rev. 26: 230-235
98. 98 Seeburg P. H. (1993) The TiPS/TINS lecture: the molecular biology of mammalian glutamate receptor channels. Trends Pharmacol. Sci. 14: 297-303
99. 99 Mori H. and Mishina M. (1995) Structure and function of the NMDA receptor channel. Neuropharmacol. 34: 1219-1237
100. 100 Sucher N. J., Awobuluyi M., Choi Y. B. and Lipton S. A. (1996) NMDA receptors: from genes to channels. Trends Pharmacol. Sci. 17: 348-355
101. 101 MacDermott A. B., Mayer M. L., Westbrook G. L., Smith S. J. and Barker J. L. (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321: 519-522
102. 102 Mayer M. L. and Westbrook G. L. (1987) The physiology of excitatory amino acids in the vertebrate central nervous system. Prog. Neurobiol. 28: 197-276
103. 2+ of NMDA responses in spinal cord neurones. Nature 309: 261-263
104. 104 Nowak L., Bregestovski P., Ascher P., Herbet A. and Prochiantz A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462-465
105. 105 Collingridge G. L., Kehl S. J. and McLennan H. (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334: 33-46
106. 106 Nicoll R. A. and Malenka R. C. (1995) Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 377: 115-118
107. 107 Kirkwood A. and Bear M. F. (1995) Elementary forms of synaptic plasticity in the visual cortex. Biol. Res. 28: 73-80
108. 108 Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39
109. 109 Morris R. G., Anderson E., Lynch G. S. and Baudry M. (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319: 774-776
110. 110 Rothman S. M. and Olney J. W. (1995) Excitotoxicity and the NMDA receptor still lethal after eight years. Trends Neurosci. 18: 57-58
111. 111 Choi D. W. (1994) Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100: 47-51
112. 112 Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330: 613-622
113. 113 Michaelis E. K. (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54: 369-415
114. 114 Johnson J. W. and Ascher P. (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529-531
115. 115 Kleckner N. W. and Dingledine R. (1988) Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 835-837
116. 3H]MK-801 binding to the N-methyl-D-aspartate receptorion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51: 830-836
117. 117 Sprosen T. S. and Woodruff G. N. (1990) Polyamines potentiate NMDA induced whole-cell currents in cultured striatal neurons. Eur. J. Pharmacol. 179: 477-478
118. 118 Peters S., Koh J. and Choi D. W. (1987) Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science 236: 589-593
119. 2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature 328: 640-643
120. 120 Traynelis S. F. and Cull-Candy S. G. (1990) Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345: 347-350
121. 121 Vyklicky L., Vlachova V. and Krusek J. (1990) The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones. J. Physiol. 430: 497-517
122. 122 Miller B., Sarantis M., Traynelis S. F. and Attwell D. (1992) Potentiation of NMDA receptor currents by arachidonic acid. Nature 355: 722-725
123. 123 Nishikawa M., Kimura S. and Akaike N. (1994) Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex. J. Physiol. 475: 83-93
124. 124 Aizenman F., Lipton S. A. and Loring R. H. (1989) Selective modulation of NMDA responses by reduction and oxidation. Neuron 2: 1257-1263
125. 125 Ozawa S., Kamiya H. and Tsuzuki K. (1998) Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54: 581-618
126. 126 Clements J. D., Lester R. A., Tong G., Jahr C. E. and Westbrook G. L. (1992) The time course of glutamate in the synaptic cleft. Science 258: 1498-1501
127. 127 Lerma J. (1997) Kainate reveals its targets. Neuron 19: 1155-1158
128. 128 Lerma J., Morales M., Vicente M. A. and Herreras O. (1997) Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci. 20: 9-12
129. 129 Paternain A. V., Morales M. and Lerma J. (1995) Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14: 185-189
130. 130 Mosbacher J., Sehoepfer R., Monyer H., Burnashev N., Seeburg P. H. and Ruppersberg J. P. (1994) A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266: 1059-1062
131. 131 Colquhoun D., Jonas P. and Sakmann B. (1992) Action of brief pulses of glutamate on AMPA kainate receptors in patches from different neurones of rat hippocampal slices. J. Physiol. 458: 261-287
132. 132 Swanson G. T., Gereau R. W., Green T. and Heinemann S. F. (1997) Identification of amino acid residues that control functional behavior in GluR5 and GluR6 kainate receptors. Neuron 19: 913-926
133. 133 Quasha A. L., Eger E. I. and Tinker J. H. (1980) Determination and applications of MAC. Anesthesiol. 53: 315-334
134. 134 Eger E. I., Saidman L. J. and Brandstater B. (1965) Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiol. 26: 756-763
135. 135 Iselin-Chaves I. A., Flaishon R., Sebel P. S., Howell S., Gan T. J., Sigl J. et al. (1998) The effect of the interaction of propofol and alfentanil on recall, loss of consciousness, and the bispectral index. Anesth. Analg. 87: 949-955
136. 136 Chortkoff B. S., Gonsowski C. T., Bennett H. L., Levinson B., Crankshaw D. P., Dutton R. C. et al. (1995) Subanesthetic concentrations of desflurane and propofol suppress recall of emotionally charged information. Anesth. Analg. 81: 728-736
137. 137 Chortkoff B. S., Eger E. I., Crankshaw D. P., Gonsowski C. T., Dutton R. C. and Ionescu P. (1995) Concentrations of desflurane and propofol that suppress response to command in humans. Anesth. Analg. 81: 737-743
138. 138 Franks N. P. and Lieb W. R. (1996) Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiol. 84: 716-720
139. A receptors. Anesthesiol. 90: 484-491
140. 140 Sear J. W. and Prys-Roberts C. (1979) Plasma concentrations of alphaxalone during continuous infusion of Althesin. Br. J. Anaesth. 51: 861-865
141. 141 Cohen M. L., Chan S. L., Way W. L. and Trevor A. J. (1973) Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiol. 39:370-376
142. 142 Sonner J. M., Li J. and Eger E. I. (1998) Desflurane and the non-immobilizer 1,2-dichlorohexafluorocyclobutane suppress learning and memory by a mechanism independent of the level of unconditioned stimulation. Anesth. Analg. 87: 200-205
143. 143 Alifimoff J. K., Firestone L. L. and Miller K. W. (1989) Anaesthetic potencies of primary alkanols: implications for the molecular dimensions of the anaesthetic site. Br. J. Pharmacol. 96: 9-16
144. 144 Antognini J. F. and Schwartz K. (1993) Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiol. 79: 1244-1249
145. 145 Collins J. G., Kendig J. J. and Mason P. (1995) Anesthetic actions within the spinal cord: contributions to the state of general anesthesia. Trends Neurosci. 18: 549-553
146. 146 Rampil I. J., Mason P. and Singh H. (1993) Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiol. 78: 707-712
147. 147 Harrison N. L. (1998) Optical isomers open a new window on anesthetic mechanism. Anesthesiol. 88: 566-568
148. 148 Heykants J. J., Meuldermans W. E., Michiels L. J., Lewi P. J. and Janssen P. A. (1975) Distribution, metabolism and excretion of etomidate, a short-acting hypnotic drug, in the rat. Comparative study of (R)-( + ) and S-( - )-Etomidate. Arch. Intl. Pharmacodyn. Ther. 216: 113-129
149. 149 Andrews P. R. and Mark L. C. (1982) Structural specificity of barbiturates and related drugs. Anesthesiol. 57: 314-320
150. 150 Lysko G. S., Robinson J. L., Casto R. and Ferrone R. A. (1994) The stereospecific effects of isoflurane isomers in vivo. Eur. J. Pharmacol. 263: 25-29
151. 151 Harris B., Moody E. and Skolnick P. (1992) Isoflurane anesthesia is stereoselective. Eur. J. Pharmacol. 217: 215-216
152. 152 Eger E. I., Koblin D. D., Laster M. J., Schurig V., Juza M., Ionescu P. et al. (1997) Minimum alveolar anesthetic concentration values for the enantiomers of isoflurane differ minimally. Anesth. Analg. 85: 188-192
153. 153 White P. F., Schuttler J., Shafer A., Stanski D. R., Horai Y. and Trevor A. J. (1985) Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br. J. Anaesth. 57: 197-203
154. 154 Ryder S., Way W. L. and Trevor A. J. (1978) Comparative pharmacology of the optical isomers of ketamine in mice. Eur. J. Pharmacol. 49: 15-23
155. A receptor modulation and anesthesia. Mol. Pharmacol. 50: 1581-1586
156. 156 Moody E. J., Harris B. D. and Skolnick P. (1994) The potential for safer anaesthesia using stereoselective anaesthetics. Trends Pharmacol. Sci. 15: 387-391
157. 157 Dickinson R., Franks N. P. and Lieb W. R. (1994) Can the stercoselective effects of the anesthetic isoflurane be accounted for by lipid solubility? Biophys. J. 66: 2019-2023
158. A receptors. Anesthesiol., in press
159. 159 Huang L. Y. and Barker J. L. (1980) Pentobarbital: stereospecific actions of ( + ) and ( ) isomers revealed on cultured mammalian neurons. Science 207: 195-197
160. 160 Jones M. V. and Harrison N. L. (1993) Effects of volatile anesthetics on the kinetics of inhibitory postsynaptic currents in cultured rat hippocampal neurons. J. Neurophysiol. 70: 1339-1349
161. A receptor. Br. J. Pharmacol. 112: 906-910
162. 162 Atkinson R. M., Davis B., Pratt M. A., Sharpe H. M. and Tomich E. G. (1965) Action of some steroids on the central nervous system of the mouse. J. Med. Chem. 8: 426-432
163. 163 Lodge D., Anis N. A. and Burton N. R. (1982) Effects of optical isomers of ketamine on excitation of cat and rat spinal neurones by amino acids and acetylcholine. Neurosci. Lett. 29: 281-286
164. 164 Roth S. H., Forman S. A., Braswell L. M. and Miller K. W. (1989) Actions of pentobarbital enantiomers on nicotinic cholinergic receptors. Mol. Pharmacol. 36: 874-880
165. 165 de Armendi A. J., Tonner P. H., Bugge B. and Miller K. W. (1993) Barbiturate action is dependent on the conformational state of the acetylcholine receptor. Anesthesiol. 79: 1033-1041
166. 166 Koblin D. D., Chortkoff B. S., Laster M. J., Eger E. I., Halsey M. J. and Ionescu P. (1994) Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth. Analg. 79: 1043-1048
167. 167 Olsen R. W. and Snowman A. M. (1982) Chloride-dependent enhancement by barbiturates of γ-aminobutyric acid receptor binding. J. Neurosci. 2: 1812-1823
168. 168 Harris B. D., Wong G., Moody E. J. and Skolnick P. (1995) Different subunit requirements for volatile and nonvolatile anesthetics at γ-aminobutyric acid type A receptors. Mol. Pharmacol. 47: 363-367
169. 169 Eckenhoff R. G. (1996) An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 93: 2807-2810
170. A receptor. Trends Pharmacol. Sci. 18: 425-429
171. A receptors with flunitrazepam identifies a subset of ligands that interact directly with His102 of the α subnit and predicts orientation of these within the benzodiazepine pharmacophore. Mol. Pharmacol. 54: 33-43
172. 172 Homanics G. E., Quinlan J. J., Mihalek R. M. and Firestone L. L. (1998) Alcohol and anesthetic mechanisms in genetically engineered mice. Front. Biosci. 3: D548-D558
173. 173 Gunther U., Benson J., Benke D., Fritschy J. M., Reyes G., Knoflach F. et al. (1995) Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. USA 92: 7749-7753
174. A receptor subunit for benzodiazepine pharmacology. Nature 338: 582-585
175. 2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic and anesthetic-sparing responses in vivo. Proc. Natl. Acad. Sci. USA 94: 9950-9955
176. A receptors in neurons of β3 subunit knockout mice. Neurosci. Lett. 240: 81-84
177. 177 Homanics G. E., DeLorey T. M., Firestone L. L., Quinlan J. J., Handforth A., Harrison N. L. et al. (1997) Mice devoid of γ-aminobutyric type A receptor γ3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. USA 94: 4143-4148
178. 178 Homanics G. E., Ferguson C., Quinlan J. J., Daggett J., Snyder K., Lagenaur C. et al. (1997) Gene knockout of the α6 subunit of the γ-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthesia. Mol. Pharmacol. 51: 588-596
179. 179 Homanics G. E., Harrison N. L., Quinlan J. J., Krasowski M. D., Rick C. E. M., de Blas A. L. et al. (1999) Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the γ2 subunit of γ-aminobutyrate type A receptor. Neuropharmacol. 38: 253-265
180. 180 Picciotto M. R., Zoli M., Rimondini R., Lena C., Marubio L. M., Pich E. M. et al. (1998) Acetycholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177
181. 181 Orr-Urtreger A., Goldner F. M., Sacki M., Lorenzo I., Goldberg L., De Biasi M. et al. (1997) Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17: 9165-9171
182. 182 Jia Z., Agopyan N., Miu P., Xiong Z., Henderson J., Gerlai R. et al. (1996) Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17: 945-956
183. 183 Das S., Sasaki Y. F., Rothe T., Premkumar L. S., Takasu M., Crandall J. E. et al. (1998) Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393: 377-381
184. 184 Forrest D., Yuzaki M., Soares H. D., Ng L., Luk D. C., Sheng M. et al. (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13: 325-338
185. 185 Kadotani H., Hirano T., Masugi M., Nakamura K., Nakao K., Katsuki M. et al. (1996) Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J. Neurosci. 16: 7859-7867
186. 186 Ebralidze A. K., Rossi D. J., Tonegawa S. and Slater N. T. (1996) Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J. Neurosci. 16: 5014-5025
187. 187 Mulle C., Sailer A., Perez-Otano I., Dickinson-Anson H., Castillo P. E., Bureau I. et al. (1998) Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392: 601-605
188. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman Syndrome. J. Neurosci. 18: 8505-8514
189. 189 Quinlan J. J., Homanics G. E. and Firestone L. L. (1998) Anesthesia sensitivity in mice that lack the β3 subunit of the γ-aminobutyric acid type A receptors. Anesthesiol. 88: 775-780
190. - current correlates with in vivo anesthetic potency. J. Pharmacol. Exp. Ther. 270: 987-991
191. A) receptors. Neuropharmacol. 26: 923-930
192. 192 Franks N. P., Dickinson R., de Sousa S. L. M., Hall A. C. and Lieb W. R. (1998) How does xenon produce anaesthesia? Nature 396: 324
193. A-mediated chloride currents in acutely dissociated hippocampal neurons. Anesthesiol. 88: 473-480
194. 194 Mennerick S., Jevtovic-Todorovic V., Todorovic S. M., Shen W. X., Olney J. W. and Zorumski C. F. (1998) Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J. Neurosci. 18: 9716-9726
195. 195 Jevtovic-Todorovic V., Todorovic S. M., Mennerick S., Powell S., Dikranian K., Benshoff N. et al. (1998) Nitrous oxide (laughing gas) is an NMDA antagonist neuroprotectant, and neurotoxin. Nature Med. 4: 460-463
196. 196 Nicoll R. A., Eccles J. C., Oshima T. and Rubia F. (1975) Prolongation of hippocampal inhibitory postsynaptic potentials by barbiturates. Nature 258: 625-627
197. 197 Scholfield C. N. (1980) Potentiation of inhibition by general anaesthetics in neurones of the olfactory cortex in vitro. Pflugers Archiv. 383: 249-255
198. A IPSCs: dissociation of blocking and prolonging effects. Anesthesiol. 90: 120-134
199. 199 Harrison N. L., Vicini S. and Barker J. L. (1987) A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J. Neurosci. 7: 604-609
200. A-mediated neuronal inhibition. Ann. N. Y. Acad. Sci. 625: 91-96
201. 201 Barker J. L. and Ransom B. R. (1978) Pentobarbitone pharmacology of mammalian central neurones grown in tissue culture. J. Physiol. 280: 355-372
202. A chloride channels in mammalian dorsal root ganglion neurones. Br. J. Pharmacol. 98: 167-176
203. A receptors by barbiturates in cultured rat hippocampal neurons. J. Physiol. 497: 509-522
204. 204 Hill-Venning C., Belelli D., Peters J. A. and Lambert J. J. (1997) Subunit-dependent interaction of the general anaesthetic etomidate with the γ-aminobutyric acid type A receptor. Br. J. Pharmacol. 120: 749-756
205. 205 Sanna E., Murgia A., Casula A. and Biggio G. (1997) Differential subunit dependence of the actions of the general anesthetics alphaxalone and etomidate at γ-aminobutyric acid type A receptors expressed in Xenopus laeris oocytes. Mol. Pharmacol. 51: 484-490
206. A receptor distinct from that for isoflurane. Mol. Pharmacol. 53: 530-538
207. 207 Hales T. G. and Lambert J. J. (1991) The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br. J. Pharmacol. 104: 619-628
208. A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiol. 79: 781-788
209. A receptors of clonal murine hypothalamic GT1-7 neurones by propofol. Br. J. Pharmacol. 115: 953-960
210. A receptor by propofol is independent of the γ subunit. J. Pharmacol. Exp. Ther. 274: 962-968
211. A receptor modulation by propofol. Neuropharmacol. 36: 941-949
212. A receptor by progesterone metabolites. Proc. R. Soc. Lond. Ser. B. Biol. Sci. 231: 359-369
213. 213 Belelli D., Callachan H., Hill-Venning C., Peters J. A. and Lambert J. J. (1996) Interaction of positive allosteric modulators with human and Drasophila recombinant GABA receptors expressed in Xenopus laeris oocytes. Br. J. Pharmacol. 118: 563-576
214. 214 Yang J., Isenberg K. E. and Zorumski C. F. (1992) Volatile anesthetics gate a chloride current in postnatal rat hippocampal neurons. FASEB J. 6: 914-918
215. A receptor needs two homologous domains of the β-subunit for activation by GABA but not by pentobarbital. Nature 366: 565-569
216. 216 Downie D. L., Hall A. C., Lieb W. R. and Franks N. P. (1996) Effects of inhalational general anaesthetics on native glycine receptors in rat medullary neurones and recombinant glycine receptors in Xenopus oocytes. Br. J. Pharmacol. 118: 493-502
217. A/glycine receptors: expression and barbiturate pharmacology. Neuropharmacol. 35: 1445-1456
218. 2 subunits expressed in Xenopus oocytes. J. Membr. Biol. 164: 115-124
219. A and glycine receptors. Nature 389: 385-389
220. 220 Wick M. J., Mihic S. J., Ueno S., Mascia M. P., Trudell J. R., Brozowski S. J. et al. (1998) Mutations of γ-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc. Natl. Acad. Sci. USA 95: 6504-6509
221. 221 Yu D., Zhang L., Eisele J. L., Bertrand D., Changeux J. P. and Weight F. F. (1996) Ethanol inhibition of nicotinic acetylcholine type α7 receptors involves the amino-terminal domain of the receptor. Mol. Pharmacol. 50: 1010-1016
222. 3 receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 120: 353-355
223. 223 Minami K., Wick S. J., Stern-Bach Y., Dildy-Mayfield J. E., Brozowski S. J., Gonzales E. L. et al. (1998) Sites of volatile anesthetic action on kainate (glutamate receptor 6) receptors. J. Biol. Chem. 273: 8248-8255
224. A subunits specify their selective interaction in vitro. J. Neurochem. 70: 40-46
225. 225 Eisele J. L., Bertrand S., Galzi J. L., Devillers-Thiery A., Changeux J. P. and Bertrand D. (1993) Chimaeric nicotinic-serotonergic receptor combines distinct tigand binding and channel specificities. Nature 366: 479-483
226. 226 Ye Q., Koltchine V. V., Mihic S. J., Mascia M. P., Wick M., Finn S. L. et al. (1998) Enhancement of glycine receptor function by erhanol is inversely correlated with molecular volume at position α267. J. Biol. Chem. 273: 3314-3319
227. A, glycine and GABA ρ1 receptors. J. Pharmacol. Exp. Ther. 284: 934-942
228. 228 Belelli D., Lambert J. J., Peters J. A., Wafford K. and Whiting P. J. (1997) The interaction of the general anesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid. Proc. Natl. Acad. Sci. USA 94: 11031-11036
229. 229 McGurk K. A., Pistis M., Belelli D., Hope A. G. and Lambert J. J. (1998) The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor. Br. J. Pharmacol. 124: 13-20
230. 230 Sonner J., Li J. and Eger E. I. (1998) Desflurane and nitrous oxide, but not non-immobilizers, affect nociceptive responses. Anesth. Analg. 86: 629-634
231. 231 Kandel L., Chortkoff B. S., Sonner J., Laster M. J. and Eger E. I. (1996) Nonanesthetics can suppress learning. Anesth. Analg. 82: 321-326
232. 232 Mihic S. J., McQuilkin S. J., Eger E. I., Ionescu P. and Harris R. A. (1994) Potentiation of γ-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Mol. Pharmacol. 46: 851-857
233. 233 Mascia M. P., Machu T. K. and Harris R. A. (1996) Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br. J. Pharmacol. 119: 1331-1336
234. 1 receptor GABAergic currents by alcohols and volatile anesthetics. J. Pharmacol. Exp. Ther. 277: 411-416
235. 3 receptors expressed in Xenopus laeris oocytes. J. Pharmacol. Exp. Ther. 271: 898-905
236. 236 Cardoso R. A., Brozowski S. J., Chavez-Noriega L. E. and Harris R. A. (1999) Human neuronal nicotinic acetylchloline receptors expressed in Xenopus oocytes predict efficacy of halogenated compounds that disobey the Meyer-Overton rule. Anesthesiol, in press
237. 237 Dildy-Mayfield J. E., Eger E. I. and Harris R. A. (1996) Anesthetics produce subunit-selective actions on glutamate receptors. J. Pharmacol. Exp. Ther. 276: 1058-1065
238. 238 Minami K., Vanderah T. W., Minami M. and Harris R. A. (1997) Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 339: 237-244
239. 239 Forman S. A. and Raines D. E. (1998) Nonanesthetic volatile drugs obey the Meyer-Overton correlation in two molecular protein site models. Anesthesiol. 88: 1535-1548
240. 240 Minami K., Gereau R. W., Minami M., Heinemann S. F. and Harris R. A. (1998) Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laeris oocytes. Mol. Pharmacol. 53: 148-156
241. 241 Cullen S. C. and Gross F. G. (1951) The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 113: 580-582
242. 242 Koblin D. D., Fang Z., Eger E. I., Laster M. J., Gong D., Ionescu P. et al. (1998) Minimum alveolar concentrations of noble gases, nitrogen and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthelics). Anesth. Analg. 87: 419-424
243. A and glycine receptors expressed in Xenopus laeris oocytes: a comparative study. Br. J. Pharmacol. 122: 1707-1719
244. A receptors. J. Neurochem. 69: 1310-1313
245. 245 Sanna E., Garau F. and Harris R. A. (1995) Novel properties of homomeric β1 γ-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital. Mol. Pharmacol. 47: 213-217
246. A receptors: influence of receptor subunits. J. Pharmacol. Exp. Ther. 274: 353-360
247. A receptor function. I. The effect of 6-methyl substitution on the electrophysiological activity of 7-substituted benz[e]indene-3-carbonitriles. J. Med. Chem. 36: 3956-3967
248. 248 Rupprecht R., Berning B., Hauser C. A., Holsboer F. and Reul J. M. (1996) Steroid receptor-mediated effects of neuroactive steroids: characterization of structure-activity relationship. Eur. J. Pharmacol. 303: 227-234
249. A receptor complex. J. Pharmacol. Exp. Ther. 241: 346-353
250. 250 Harrison N. L. and Simmonds M. A. (1984) Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323: 287-292
251. A receptor activity by alphaxalone. Br. J. Pharmacol. 90: 491-500
252. A receptors in cultured hippocampal neurons and transfected HEK-293 cells. Neuropharmacol. 35: 1161-1168
253. A receptor activity by the novel water-soluble aminosteroid Org 20599. Neuropharmacol. 35: 1209-1222
254. A receptors. J. Pharmacol. Exp. Ther. 287: 198-207
255. A receptor at sites on the N-terminal side of the middle of TM2. Neuroreport 9: 379-383
256. 256 Sawada S. and Yamamoto C. (1985) Blocking action of pentobarbital on receptors for excitatory amino acids in the guinea pig hippocampus. Exp. Brain Res. 59: 226-231
257. 257 Marszalec W. and Narahashi T. (1993) Use-dependent pentobarbital block of kainate and quisqualate currents. Brain Res. 608: 7-15
258. 258 YamakuraT., Sakimura K., Mishina M. and Shimoji K. (1995) The sensitivity of AMPA-sensitive glutamate receptor channels to pentobarbital is determined by a single amino acid residue of the alpha 2 subunit. FEBS Lett. 374: 412-414
259. 259 Lomeli H., Mosbacher J., Melcher T., Hoger T., Geiger J. R., Kuner T. et al. (1994) Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266: 1709-1713
260. 260 Sommer B., Kohler M., Sprengel R. and Seeburg P. H. (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67: 11019
261. A receptor. J. Membr. Biol. 155: 157-166
262. 262 Winters W. D., Ferrar-Allado T., Guzman-Flores C. and Alcaraz M. (1972) The cataleptic state induced by ketamine: a review of the neuropharmacology of anesthesia. Neuropharmacol. 11: 303-315
263. 263 Orser B. A., Pennefather P. S. and MacDonald J. F. (1997) Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiol. 86: 903-917
264. 264 Anis N. A., Berry S. C., Burton N. R. and Lodge D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 79: 565-575
265. 265 Zeilhofer H. U., Swandulla D., Geisslinger G. and Brune K. (1992) Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur. J. Pharmacol. 213: 155-158
266. 266 Nagata K., Aistrup G. L., Huang C. S., Marszalec W., Song J. H., Yeh J. Z. et al. (1996) Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol. Neurosci. Lett. 217: 189-193
267. 267 Covernton P. J. and Connolly J. G. (1997) Differential modulation of rat neuronal nicotinic receptor subtypes by acute application of ethanol. Br. J. Pharmacol. 122: 1661-1668
268. 268 Deitrich R. A. and Harris R. A. (1996) How much alcohol should I use in my experiments? Alcoholism Clin. Exp. Res. 20: 1-2
269. 269 McCreery M. J. and Hunt W. A. (1978) Physico-chemical correlates of alcohol intoxication. Neuropharmacol. 17: 451-461
270. 270 Lyon R. C., McComb J. A., Schreurs J. and Goldstein D. B. (1981) A relationship between alcohol intoxication and the disordering of brain membranes by a series of short-chain alcohols. J. Pharmacol. Exp. Ther. 218: 669-675
271. A and glutamate receptors: relation to in vivo effects. Br. J. Pharmacol. 118: 378-384
272. 272 Franks N. P., Jenkins A., Conti L., Lieh W. R. and Brick P. (1998) Structural basis for the inhibition of firefly luciferase by a general anesthetic. Biophys. J. 75: 2205-2211
273. + conduction and selectivity. Science 280: 69-77
274. 274 Armstrong N., Sun Y., Chen G. Q. and Gouax E. (1998) Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 395: 913-917
275. 275 Giese J. L. and Stanley T. H. (1983) Etomidate: a new intravenous anesthetic induction agent. Pharmacotherapy 3: 251-258
276. 276 Lauven P. M., Schwilden H. and Stoeckel H. (1987) Threshold hypnotic concentration of methohexitone. Eur. J. Clin. Pharmacol. 33: 261-265
277. 277 Idvall J., Ahlgren I., Aronsen K. F. and Stenberg P. (1979) Ketamine infusions: pharmacokinetics and clinical effects. Br. J. Anaesth. 51: 1167-1172
278. 278 Fang Z., Ionescu P., Chortkoff B. S., Kandel L., Sonner J., Laster M. J. et al. (1997) Anesthetic potencies of n-alkanols: results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth. Analg. 84: 1042-1048
279. 279 McKenzie D., Franks N. P. and Lieb W. R. (1995) Actions of general anaesthetics on a neuronal nicotinic acetylcholine receptor in isolated identified neurones of Lymnaea stagnalis. Br. J. Pharmacol. 115: 275-282
280. A receptors. Mol. Pharmacol. 43: 970-975
281. 281 Hadingham K. L., Wingrove P. B., Wafford K. A., Bain C., Kemp J. A., Palmer K. J. et al. (1993) Role of the β subunit in determining the pharmacology of human γ-aminobutyric acid type A receptors. Mol. Pharmacol. 44: 1211-1218
282. A receptor α1 subunit. J. Gen. Physiol. 107: 195-205
283. A channel that abolish block by picrotoxin. Receptors Channels 3: 13-20
284. 3 subunit. Proc. Natl. Acad. Sci. USA 91: 4569-4573
285. A receptors. Mol. Pharmacol. 53: 870-877
286. 286 Miller K. W. and Smith E. B. (1973) Intermolecular forces and the pharmacology of simple molecules. In: A Guide to Molecular Pharmacology - Toxicology, part 2, pp. 427-475, Featherstone R. M. (ed.). Marcel Dekker, New York
287. 287 Eger E. I., Lundgren C., Miller S. L. and Stevens W. C. (1969) Anesthetic potencies of sulfur hexafluoride, carbon tetrafluoride, chloroform and Ethrane in dogs: correlation with the hydrate and lipid theories of anesthetic action. Anesthesiol. 30: 129-135
288. 288 Steward A., Allott P. R., Cowles A. L. and Mapleson W. W. (1973) Solubility coefficients for inhaled anaesthetics for water, oil and biological media. Br. J. Anaesth. 45: 282-293
289. 289 Mazze R. I., Rice S. A. and Baden J. M. (1985) Halothane, isoflurane, and enflurane MAC in pregnant and nonpregnant female and male mice and rats. Anesthesiol. 62: 339-341
290. 290 Koblin D. D. (1994) Mechanisms of action. In: Anesthesia, pp. 67-69, Miller R. D. (ed.), Churchill Livingstone, New York
291. 291 Crawford M. W., Lerman J., Saldivia V. and Carmichael F. J. (1992) Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesth. Analg. 75: 1000-1006
292. 292 Kazama T. and Ikeda K. (1988) Comparison of MAC and the rate or rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiol. 68: 435-437
293. 293 Scheller M. S., Saidman L. J. and Partridge B. L. (1988) MAC of sevoflurane in humans and the New Zealand white rabbit. Can. J. Anaesth. 35: 153-156
294. 294 Halsey M. J., Wardley-Smith B. and Wood S. (1986) Pressure reversal of alphaxalone/alphadolone and methohexitone in tadpoles: evidence for different molecular sites for general anaesthesia. Br. J. Pharmacol. 89: 299-305
295. 295 Tonner P. H., Scholz J., Lamberz L., Schlamp N. and Schulte J. (1997) Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in Xenopus laeris. Anesthesiol. 87: 1479-1485
296. 296 Pringle M. J., Brown K. B. and Miller K. W. (1981) Can the lipid theories of anesthesia account for the cutoff in anesthetic potency in homologous series of alcohols? Mol. Pharmacol. 19: 49-55
297. 297 Brink F. and Posternak J. M. (1948) Thermodynamic analysis of the relative effectiveness of narcotics. J. Cell. Comput. Physiol. 32: 211-233
298. 298 Marshall E. K. and Owens A. H. (1954) Absorption, excretion, and metabolic late of chloral hydrate and trichloroethanol. Bull. Johns Hopkins Hosp. 95: 1-18
299. 299 Breimer D. D. (1977) Clinical pharmacokinetics of hypnotics. Clin. Pharmacokinet. 2: 93-109
300. 300 Garrett E. R. and Lambert H. J. (1973) Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters. J. Pharm. Sci. 62: 550-572
301. 301 Daniels S. and Roberts R. J. (1998) Post-synaptic inhibitory mechanisms of anaesthesia: glycine receptors. Toxicol. Lett. 100: 71-76
302. 302 Carla V. and Moroni F. (1992) General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci. Lett. 146: 21-24
303. A receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium. J. Pharmacol. Exp. Ther. 263: 569-578
304. 304 Dilger J. P., Liu Y. and Vidal A. M. (1995) Interactions of general anaesthetics with single acetylcholine receptor channels. Eur. J. Anaesth. 12: 31-39
305. 3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells. J. Pharmacol. Exp. Ther. 278: 732-740
306. A receptor structure. J. Neurochem. 60: 1548-1553
307. 307 Wakamori M., Ikemoto Y. and Akaike N. (1991) Effects of two volatile anesthetics and a volatile convulsant on the excitatory and inhibitory amino acid responses in dissociated CNS neurons of the rat. J. Neurophysiol. 66: 2014-2021
308. - currents in cultured rat hippocampal neurones by three volatile anaesthetics. J. Physiol. 449: 279-293
309. 309 Nakahiro M., Yeh J. Z., Brunner E. and Narahashi T. (1989) General anesthetics modulate GABA receptor channel complex in rat dorsal root ganglion neurons. FASEB J. 3: 1850-1854
310. 310 Wachtel R. E. (1995) Relative potencies of volatile anesthetics in altering the kinetics of ion channels in BC3H1 cells. J. Pharmacol. Exp. Ther. 274: 1355-1361
311. 3 receptors in N1E-115 neuroblastoma cells. Br. J. Pharmacol. 117: 1507-1515
312. 312 Lin L. H., Chen L. L. and Harris R. A. (1993) Enflurane inhibits NMDA, AMPA, and kainate-induced currents in Xenopus oocytes expressing mouse and human brain mRNA. FASEB J. 7: 479-485
313. A receptor-chloride channel complex. Toxicol. Lett. 101: 225-231
314. 314 Mascia M. P., Wick M. J., Martinez L. D. and Harris R. A. (1998) Enhancement of glycine receptor function by ethanol: role of phosphorylarion. Br. J. Pharmacol. 125: 263-270
315. 315 Violet J. M., Downie D. L., Nakisa R. C., Lieb W. R. and Franks N. P. (1997) Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiol. 86: 866-874
316. 316 Dickinson R., Lieb W. R. and Franks N. P. (1995) The effects of temperature on the interactions between volatile general anaesthetics and a neuronal nicotinic acetylcholine receptor. Br. J. Pharmacol. 116: 2949-2956
317. 317 Weight F. F., Peoples R. W., Wright J. M., Lovinger D. M. and White G. (1993) Ethanol action on excitatory amino acid activated ion channels. Alcohol Alcoholism Suppl. 2: 353-358
318. 318 Harrison N. L., Kugler J. L., Jones M. V., Greenblatt E. P. and Pritchett D. B. (1993) Positive modulation of human γ-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. Mol. Pharmacol. 44: 628-632
319. A receptors by isoflurane: influence of the delta subunit. Anesthesiol. 88: 206-217
320. 320 Scheller M., Bufler J., Schneck H., Kochs E. and Franke C. (1997) Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations. Anesthesiol. 86: 118-127
321. 321 Flood P., Ramirez-Latorre J. and Role L. (1997) α4β2 Neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but α7-type nicotinic acetylcholine receptors are unaffected. Anesthesiol. 86: 859-865
322. 322 Charlesworth P. and Richards C. D. (1995) Anaesthetic modulation of nicotinic ion channel kinetics in bovine chromaffin cells. Br. J. Pharmacol. 114: 909-917
323. 323 Kira T., Harata N., Sakata T. and Akaike N. (1998) Kinetics of sevoflurane action on GABA-and glycine-induced currents in acutely dissociated rat hippocampal neurons. Neuroscience 85: 383-394
324. 324 Wu J., Harata N. and Akaike N. (1996) Potentiation by sevoflurane of the γ-aminobutyric acid-induced chloride current in acutely dissociated CA1 pyramidal neurones from rat hippocampus. Br. J. Pharmacol. 119: 1013-1021
325. A receptors containing bovine α1, β1, γ2L sub-units stably transfected into mouse fibroblast L-cells. Br. J. Pharmacol. 107: 732-737
326. A receptor by depressant barbiturates and pregnane steroids. Br. J. Pharmacol. 94: 1257-1269
327. A receptor: dependence on receptor subunit combination. Br. J. Pharmacol. 117: 521-527
328. 328 Parker I., Gundersen C. B. and Miledi R. (1986) Actions of pentobarbital on rat brain receptors expressed in Xenopus oocytes. J. Neurosci. 6: 2290-2297
329. 329 Shimada S., Cutting G. and Uhl G. R. (1992) γ-Aminobutyric acid A or C receptor? γ-Aminobutyric acid ρ1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive γ-aminobutyric acid responses in Xenopus oocytes. Mol. Pharmacol. 41: 683-687
330. 330 Gage P. W. and McKinnon D. (1985) Effects of pentobarbitone on acetylcholine-activated channels in mammalian muscle. Br. J. Pharmacol. 85: 229-235
331. 331 Dilger J. P., Boguslavsky R., Barann M., Katz T. and Vidal A. M. (1997) Mechanisms of barbiturate inhibition of acetylcholine receptor channels. J. Gen. Physiol. 109: 401-414
332. 3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital. Neuropharmacol. 36: 655-664
333. A receptor-gated currents in cultured postnatal hippocampal neurons. Neuroscience 73: 69-78
334. A receptor gated current depends on the subunit composition. Neurosci. Lett. 185: 203-206
335. 335 Wachtel R. E. and Wegrzynowicz E. S. (1992) Kinetics of nicotinic acetylcholine ion channels in the presence of intravenous anaesthetics and induction agents. Br. J. Pharmacol. 106: 623-627
336. 3 receptors. Br. J. Anaesth. 76: 271-273
337. 337 Scheller M., Bufler J., Hertle I., Schneck H. J., Franke C. and Kochs E. (1996) Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state. Anesth. Analg. 83: 830-836
338. 3 receptors a patch clamp-study. Neuropeptides 19: 25-30
339. A receptor γ1 subunit N-terminal extracellular domain in propofol potentiation of chloride current. Neuropharmacol. 36: 1611-1617
340. A response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiol. 81: 988-994
341. A receptors in cultured murine hippocampal neurons. J. Neurosci. 14: 7747-7760
342. 342 Yamakura T., Sakimura K., Shimoji K. and Mishina M. (1995) Effects of propofol on various AMPA-, kainate-and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci. Lett. 188: 187-190
343. 343 Orser B. A., Bertlik M., Wang L. Y. and MacDonald J. F. (1995) Inhibition by propofol (2,6-di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br. J. Pharmacol. 116: 1761-1768
344. 344 Barker J. L., Harrison N. L., Lange G. D. and Owen D. G. (1987) Potentialion of γ-aminobutyric-acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones. J. Physiol. 386: 485-501
345. 345 Prince R. J. and Simmonds M. A. (1992) Steroid modulation of the strychnine-sensitive glycine receptor. Neuropharmacol. 31: 201-205
346. - channels in rat retinal bipolar cells. Nature 361: 159-162
347. A receptors expressed in Xenopus oocytes. Br. J. Pharmacol., in press
348. A receptors: relevance to theories of narcosis. Anesth. Analg. 88: 877-883
349. A-and glycine-activated Cl current in cultured mouse neurons. J. Pharmacol. Exp. Ther. 270: 61-69
350. A receptor-mediated currents: lack of subunit specificity. Eur. J. Pharmacol. 268: 209-214
351. 351 Nakahiro M., Arakawa O. and Narahashi T. (1991) Modulation of γ-aminobutyric acid receptor-channel complex by alcohols. J. Pharmacol. Exp. Ther. 259: 235-240
352. 352 Marszalec W., Kurata Y., Hamilton B. J., Carter D. B. and Narahashi T. (1994) Selective effects of alcohols on γ-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells. J. Pharmacol. Exp. Ther. 269: 157-163
353. A receptor function by alcohols: effects of subunit composition and differential effects of ethanol. Alcoholism Clin. Exp. Res. 20: 1313-1319
354. - current by ethanol in cultured mouse spinal neurons. J. Pharmacol. Exp. Ther. 279: 1116-1122
355. 355 Mascia M. P., Mihic S. J., Valenzuela C. F., Schofield P. R. and Harris R. A. (1996) A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors. Mol. Pharmacol. 50: 402-406
356. 356 Bradley R. J., Sterz R. and Peper K. (1984) The effects of alcohols and diols at the nicotinic acetylcholine receptor of the neuromuscular junction. Brain Res. 295: 101-112
357. 357 Cardoso R. A., Brozowski S. J., Chavez-Noriega L. E., Harpold M., Valenzuela C. F. and Harris R. A. (1999) Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 289: 774-780
358. 3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol. Pharmacol. 40: 263-270
359. 3 receptor-mediated ion current in NCB-20 neuroblastoma cells. Neurosci. Lett. 122: 57-60
360. 360 Aoshima H. (1996) Effects of alcohols and food additives on glutamate receptors expressed in Xenopus oocytes: specificity in the inhibition of the receptors. Biosci. Biotechnol. Biochem. 60: 434-438
361. 361 Dildy-Mayfield J. E. and Harris R. A. (1995) Ethanol inhibits kainate responses of glutamate receptors expressed in Xenopus oocytes: role of calcium and protein kinase C. J. Neurosci. 15: 3162-3171
362. 362 Wright J. M., Peoples R. W. and Weight F. F. (1996) Single-channel and whole-cell analysis of ethanol inhibition of NMDA-activated currents in cultured mouse cortical and hippocampal neurons. Brain Res. 738: 249-256
363. 363 Koltchine V., Anantharam V., Wilson A., Bayley H. and Treistman S. N. (1993) Homomeric assemblies of NMDAR1 splice variants are sensitive to ethanol. Neurosci. Lett. 152: 13-16
364. 364 Lovinger D. M., White G. and Weight F. F. (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 2-13: 1721-1724
365. 365 Peoples R. W., White G., Lovinger D. M. and Weight F. F. (1997) Ethanol inhibition of N-methyl-D-aspartate-activated current in mouse hippocampal neurones: whole-cell patchclamp analysis. Br. J. Pharmacol. 122: 1035-1042
366. 366 Nakahiro M., Arakawa O., Nishimura T. and Narahashi T. (1996) Potentialion of GABA-induced Cl current by a series of n-alcohols disappears at a cutoff point of a longer-chain n-alcohol in rat dorsal root ganglion neurons. Neurosci. Lett. 205: 127-130
367. 367 Murrell R. D., Braun M. S. and Haydon D. A. (1991) Actions of n-alcohols on nicotinic acetylcholine receptor channels in cultured rat myotubes. J. Physiol. 437: 431-448
368. 368 Peoples R. W. and Weight F. F. (1995) Cutoff in potency implicates alcohol inhibition of N-methyl-D-aspartate receptors in alcohol intoxication. Proc. Natl. Acad. Sci. USA 92: 2825-2829
369. 369 McLarnon J. G., Wong J. H., Sawyer D. and Baimbridge K. G. (1991) The actions of intermediate and long-chain n-alkanols on unitary NMDA currents in hippocampal neurons. Can. J. Physiol. Pharmacol. 69: 1422-1427
370. A receptor activity by α-chloralose. J. Pharmacol. Exp. Ther. 285: 680-686
371. A receptors in hippocampal neurons. J. Pharmacol. Exp. Ther. 264: 1097-1103
372. 372 Peoples R. W. and Weight F. F. (1994) Trichloroethanol potentiation of γ-aminobutyric acid-activated chloride current in mouse hippocampal neurones. Br. J. Pharmacol. 113: 555-563
373. 3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state. J. Physiol. 507: 335-352
374. 3 receptor-mediated ion current in nodose ganglion neurons from the adult rat. J. Pharmacol. Exp. Ther. 265: 771-776
375. 3 receptors. Br. J. Pharmacol. 114: 1641-1651
376. 376 Peoples R. W. and Weight F. F. (1998) Inhibition of excitatory amino acid-activated currents by trichloroethanol and trifluoroethanol in mouse hippocampal neurones. Br. J. Pharmacol. 124: 1159-1164